13D Filing: TPG Group Holdings (SBS) Advisors, Inc. and Quintiles IMS Holdings Inc (Q)

Page 5 of 11

Page 5 of 11 – SEC Filing

CUSIP No. 74876Y101         SCHEDULE 13D Page   5   of    11   Pages
1

NAMES OF REPORTING PERSONS

TPG Biotech Advisors, Inc.

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions)
(a) ☐

(b) ☐

3 SEC USE ONLY
4

SOURCE OF FUNDS (see instructions)

OO (See Item 3)

5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) ☐ 
6

CITIZENSHIP OR PLACE OF ORGANIZATION

Delaware

NUMBER OF SHARES 7 SOLE VOTING POWER
– 0 –
BENEFICIALLY OWNED BY 8

SHARED VOTING POWER

36,935,608 (See Items 3, 4 and
5)

EACH REPORTING PERSON 9 SOLE DISPOSITIVE POWER
– 0 –
WITH 10

SHARED DISPOSITIVE POWER

36,935,608 (See Items 3, 4 and 5)

11

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

36,935,608 (See Items 3, 4 and 5)

12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (see instructions)     ☐                   
13

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

17.1% (See Item 5)*

14

TYPE OF REPORTING PERSON

CO

* The calculation is based on 215,820,842 shares of Common Stock outstanding as of May
19, 2017, as reported in the Prospectus Supplement filed by the Issuer with the Commission on May 26, 2017, after giving effect
to the May 2017 Share Repurchase.

Follow Iqvia Holdings Inc.

Page 5 of 11